![]() The Peoples Health Care is a California based non-profit organization committed to investing in the quality of care offered to the lives covered within California. Incorporating HALO Precision Diagnostics into this mission is expected to unlock care guided by integrated healthcare that is more cost effective, more accurate, and less invasive than traditional clinical diagnostic laboratory and imaging models, making them an ideal partner for Safe & Green Holdings and The Peoples Health Care. The Company plans to bring higher quality and more equitable healthcare to underserved communities, while capturing its share of what is expected to be a nearly $52B market before the turn of 2030. Safe & Green Holdings is building off of its proven business model of providing deployable and sustainable infrastructure in order to capitalize on the healthcare industry’s paradigm shift to point-of-care health models. (NASDAQ: SGBX) (“Safe & Green Holdings'' or the “Company”), a leading developer, designer, and fabricator of modular structures, announced today that the Company is further solidifying its position as a leader in proactive, patient-centered healthcare deliverance. These include the Community-Acquired Respiratory Disease Study (CARDS) of Duke University Freshman and a similar study in the Durham VA Medical Center long-term care unit.MIAMI-( BUSINESS WIRE)-Safe & Green Holdings Corp. In addition, the MERL supports several large, ongoing cohort studies for the development and validation of host response diagnostic tests. From the 7 total challenge cohorts enrolled, more than 100 volunteer subjects produced over 50,000 clinical samples that were processed and analyzed at the MERL as part of our diagnostic development program. For example, the laboratory directed the sample collection, processing, and detection of diverse respiratory viral pathogens for studies that examined early phase host response diagnostic development following human challenge studies in several offsite clinical research locations. The MERL laboratory has developed standardized operating procedures for the collection, processing, and storage of clinical research samples for use in a diverse range of clinical and epidemiological diagnostic studies. Novel assay platform development, refinement, and performance assessment.Real-time qPCR with automated plate loading.Preparation of genomic and epigenetic libraries including RNAseq and ATACseq.Specimen processing and quality assessment.The lab interfaces as well with the Duke -omics core facilities, including Genome Sequencing and Proteomics and Metabolomics Cores, to generate -omics data in support of genome-inspired discovery studies. ![]() Capabilities include genome-wide discovery assays (genomic, epigenetic, and proteome/metabolite assays) and targeted, quantitative measurements of specific gene products or analyte panels, with the goal of migrating biomarker signatures from unbiased discovery studies to targeted, multi-analyte assay platforms suitable for rapid point-of-need diagnostic use. The Precision Diagnostics Lab has standardized protocols and workflows to perform clinical research sample processing, extraction and QC, and biomarker discovery and verification analyses. Our Commitment to Diversity and Inclusion in Training.Education and Training toggle sub nav items.Pulmonary, Allergy, and Critical Care Medicine.Hematologic Malignancies and Cellular Therapy.Endocrinology, Metabolism, and Nutrition.About the Department toggle sub nav items.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |